Table 2.
Outcome | bLf group (n = 75) | Placebo group (n = 75) | Odds ratio (95% CI) | Relative risk (95% CI) |
---|---|---|---|---|
Primary, n (%) | ||||
Antibiotic-associated diarrhea | 16 (21.3) | 7 (9.3) | 2.6 (1.02–6.8) | 2.29 (0.89–5.88) |
Secondary, n (%) | ||||
Intravenous rehydration | 0 | 1 (1.28) | ||
Discontinuation of antibiotic treatment | 0 | 0 |
bLf, bovine lactoferrin.